ClinicalTrials.Veeva

Menu

Study of the Use of Non-invasive Ventilation in Bronchial Dilatation Disease (BRONCHINIV)

C

Centre Hospitalier Intercommunal Creteil

Status

Enrolling

Conditions

Bronchial Dilatation Disease
Bronchectasie

Study type

Observational

Funder types

Other

Identifiers

NCT06987461
BRONCHINIV

Details and patient eligibility

About

This is a medical record data collection study. The goal of this non-interventional and retrospective study is to describe the characteristics of the population currently being monitored for bronchial dilatation who have been treated with long-term NIV. This is a study based on data from medical records.

The assessment criteria will be :

  • Epidemiological characteristics of the population with bronchial dilatation on long-term NIV
  • Reasons for initiation of NIV
  • NIV adjustment methods

Full description

Non-invasive ventilation is a treatment sometimes used for severe severe bronchial dilatation, but to date there are no studies its efficacy.

The expected results in this context are :

  • a description of the characteristics of patients with severe bronchial on non-invasive ventilation (NIV)
  • a better understanding, during NIV management, of the settings used, the tolerance and effectiveness of NIV in reducing exacerbations, hospital admissions and patient mortality.
  • move towards better patient management

Data will be extracted from patient medical records and the PMSI.

Enrollment

70 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients over 18 years
  • Predominant diagnosis of bronchiectatic disease, excluding cystic fibrosis, confirmed by computed tomography
  • Introduction of long-term NIV at a given point in the patient's care

Exclusion criteria

  • Patient's opposition to participating in this study
  • Cystic fibrosis
  • Predominant diagnosis of COPD or asthma, traction bronchiectasis, bronchiectasis resulting from focal endobronchial lesion, sarcoidosis or active allergic bronchopulmonary aspergillosis.

Trial design

70 participants in 1 patient group

Patients with bronchial dilatation treated with non-invasive ventilation
Description:
Adult patients with predominantly cystic fibrosis bronchiectatic disease confirmed by tododensitometry, treated with NIV

Trial contacts and locations

5

Loading...

Central trial contact

Suela DEMIRI, Doctor, Hospital Practitioner

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems